Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 14 Week Study to Evaluate Effectiveness of a Valsartan Versus an Amlodipine Treatment Strategy in Achieving Blood Pressure Control in Patients With Stage 1 or Stage 2 Hypertension or Uncontrolled on Present Monotherapy

NCT00304226 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00304226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00304226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 14 Week Study to Evaluate Effectiveness of a Valsartan Versus an Amlodipine Treatment Strategy in Achieving Blood Pressure Control in Patients With Stage 1 or Stage 2 Hypertension or Uncontrolled on Present Monotherapy
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2006
Completion date
January 31, 2007
Enrollment
1,288 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension